← Ishga qaytish
Ushbu ish iqtibos qilgan ishlar
213 ta ish
Ish: Emerging strategies to reduce the side effects of CAR-T cell therapy: focusing on gene editing and nanotechnology
Side-effect management of chimeric antigen receptor (CAR) T-cell therapy
Maria‐Luisa Schubert, Michael Schmitt, L. Wang +4
Sharh maqolaOchiq kirish20202 iqtibosABITumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning
Hollie J. Pegram, James Lee, Erik Hayman +4
MaqolaOchiq kirish20122 iqtibosABIIL-12 secreting tumor-targeted chimeric antigen receptor T cells eradicate ovarian tumors <i>in vivo</i>
Mythili Koneru, Terence J. Purdon, David R. Spriggs +2
MaqolaOchiq kirish20152 iqtibosABIIL-18–secreting CAR T cells targeting DLL3 are highly effective in small cell lung cancer models
Janneke E. Jaspers, Jonathan F. Khan, William D. Godfrey +4
MaqolaOchiq kirish20232 iqtibosABICAR-T cell-derived exosomes: a new perspective for cancer therapy
Farnaz Sani, Shabnam Shojaei, Seyed Amirhossein Tabatabaei +4
Sharh maqolaOchiq kirish20242 iqtibosABIGene Editing and Genotoxicity: Targeting the Off-Targets
Georges Blattner, Alessia Cavazza, Adrian J. Thrasher +1
Sharh maqola20202 iqtibosABIEndowing universal CAR T-cell with immune-evasive properties using TALEN-gene editing
Sumin Jo, Shipra Das, Alan F. Williams +19
Maqola20222 iqtibosABI